Mississippi Right to Try Medical Cannabis Act Clears Legislature With Veto-Proof Majority

Mississippi is on the verge of a historic expansion of its medical cannabis program after lawmakers sent the Right to Try Medical Cannabis Act to Governor Tate Reeves with overwhelming bipartisan support. The legislation, which passed the House 104-7 and the Senate 34-17, would open the door for patients with serious illnesses not currently on the state's qualifying conditions list to access medical cannabis through a physician-led petition process.

Key Takeaways

• If signed, the act takes effect July 1, 2026, and would double patient recertification periods to 24 months
• Mississippi's Right to Try Medical Cannabis Act passed with veto-proof margins of 104-7 in the House and 34-17 in the Senate
• The law would allow doctors to petition the state for medical cannabis access for patients with serious conditions not on the qualifying list

Table of Contents

• What the Right to Try Medical Cannabis Act Does
• Why This Matters for Mississippi Patients
• A Broader Trend in Southern Cannabis Policy
• What Happens Next

What the Right to Try Medical Cannabis Act Does

House Bill 1152, sponsored by Representative Lee Yancey (R), creates a new pathway for patients suffering from chronic, progressive, severely disabling, or terminal illnesses to gain access to medical cannabis even when their specific condition is not among the state's officially approved qualifying conditions. Under the proposed law, a physician would submit a petition to the Mississippi Department of Health on behalf of their patient, and the state health officer would then have the authority to approve or deny those individual requests.

This approach mirrors the broader "right to try" philosophy that has gained traction across the country in recent years, which argues that patients facing serious medical conditions should have every available therapeutic option, even when a drug or treatment has not completed the traditional regulatory approval process. In the context of cannabis, it means that Mississippi doctors would gain significant new discretion in recommending medical marijuana to patients whose conditions do not fit neatly into the existing statutory framework.

The bill also includes provisions to rename "low-THC oil" as "medical cannabis" under state law, a symbolic but meaningful change that reflects the evolving understanding of the plant's therapeutic potential. Additionally, the legislation extends the period between required patient recertifications from 12 months to 24 months, reducing the administrative burden on both patients and healthcare providers.

Why This Matters for Mississippi Patients

Mississippi's existing medical cannabis program, which launched in 2022 following a voter-approved initiative that was struck down by the state Supreme Court and subsequently replaced by legislative action, has been criticized for its relatively narrow list of qualifying conditions. Patients with conditions like chronic pain syndromes, autoimmune disorders, and certain neurological conditions have found themselves unable to access medical cannabis despite growing evidence that it may offer relief.

The Right to Try Act would change that dynamic fundamentally. Rather than waiting for the legislature to add conditions one by one to the approved list, physicians could advocate directly for their patients on a case-by-case basis. Proponents argue this is both more efficient and more compassionate, putting medical decisions in the hands of doctors rather than politicians.

The veto-proof margins in both chambers are particularly significant. Governor Reeves has historically been cautious on cannabis expansion, and the strong bipartisan support signals that even a gubernatorial veto would likely be overridden. The House vote of 104-7 represents one of the most lopsided cannabis-related votes in any conservative state legislature in recent memory.

A Broader Trend in Southern Cannabis Policy

Mississippi's move comes amid a broader wave of medical cannabis expansion across the South. Georgia's House recently passed a substitute to Senate Bill 220 by a 138-21 margin, adding provisions to expand that state's medical cannabis program. Alabama launched its first medical cannabis dispensaries in recent months after years of regulatory delays.

Kentucky's medical cannabis program is also coming online, with dispensaries beginning to serve patients.

These developments reflect a shifting political reality in the Deep South. While recreational legalization remains a bridge too far for most Southern legislatures, medical cannabis has crossed a threshold of bipartisan acceptability. Conservative lawmakers who might have balked at any cannabis legislation a decade ago are now voting overwhelmingly in favor of patient access bills, often framing them in terms of individual liberty and the doctor-patient relationship.

The Right to Try framework is especially effective in these political environments because it does not require legislators to take a position on specific medical conditions or to endorse cannabis as a treatment. Instead, it defers to the medical judgment of physicians while maintaining state oversight through the Department of Health approval process.

What Happens Next

Governor Reeves has until early April to sign the bill into law, veto it, or let it become law without his signature. If enacted, the Right to Try Medical Cannabis Act would take effect on July 1, 2026, giving the Department of Health roughly three months to establish the petition and approval process.

Industry observers are watching closely. If the bill becomes law, Mississippi would join a small but growing number of states that allow physician-initiated petitions for medical cannabis access outside of a fixed qualifying conditions list. This flexible approach could serve as a model for other conservative states that want to expand patient access without fully overhauling their medical cannabis statutes.

For the roughly 15,000 registered medical cannabis patients in Mississippi, the immediate impact may be limited. But for the unknown number of patients who have been unable to qualify under the current framework, the Right to Try Act represents a genuine lifeline and a signal that even in the Deep South, the walls around cannabis access continue to come down.

Pull-Quote Suggestions:

"Mississippi is on the verge of a historic expansion of its medical cannabis program after lawmakers sent the Right to Try Medical Cannabis Act to Governor Tate Reeves with overwhelming bipartisan support."

"Governor Reeves has historically been cautious on cannabis expansion, and the strong bipartisan support signals that even a gubernatorial veto would likely be overridden."

"The Right to Try Act would change that dynamic fundamentally."

Why It Matters: Mississippi lawmakers send the Right to Try Medical Cannabis Act to Governor Reeves with overwhelming support. Learn what it means for patients statewide.